1
TÍTULO: Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection
AUTORES: Lacaze Masmonteil, T; Seidenberg, J; Mitchell, I; Cossey, V; Cihar, M; Csader, M; Baarsma, R; Valido, M; Pollack, PF; Groothuis, JR; Allegaert, K; Lombet, J; Haumont, D; Plaskie, K; Davies, HD; Sauve, RS; Langley, JM; Liska, K; Andre, P; Lequien, P; Kacet, N; Lapeyre, F; Wickenburg Ennen, B; Nolte, H; Harding, PA; Ramos, S; Carolino, M; Marques, A; ...Mais
PUBLICAÇÃO: 2003, FONTE: DRUG SAFETY, VOLUME: 26, NÚMERO: 4
INDEXADO EM: Scopus WOS